Huifeng closes $2 million convertible debt financing
The debt is convertible into shares of common stock at $1 per share and the company intends to use the proceeds to fund acquisitions of synergistic companies within
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Eli Lilly and Company’s (Lilly) olomorasib as a potential treatment for adults with advanced pancreatic cancer who have already received at least one prior systemic therapy.